Oncology 2023

Collaboration between policymakers, pharma stakeholders, and patient groups is sparking innovation as cancer research pursues its final frontier

Click here

Cancer Moonshot: A story of hope for oncology in the US

A year on from the launch of Cancer Moonshot 2.0, we take a look back at key achievements in the programme’s journey towards advancing cancer research and treatment in the US

Click here

Healthcare is a team sport: Tackling cancer inequalities in Europe

Daiichi Sankyo’s Markus Kosch and AstraZeneca’s Greg Rossi explore the importance of combining collective expertise to push the boundaries of what is possible in cancer care

Click here

The pharma world at your fingertips

Daily and weekly email newsletters from pharmaphorum – insights and analysis on the big trends shaping healthcare and the pharmaceutical industry

Click here

Heard on the pipeline: Technology in oncology

In this special round-up feature, pharmaphorum editor-in-chief Jonah Comstock hits the floor of ASCO 2023 to find out what the brightest minds in healthcare think the future holds for digital and AI technologies in cancer research

Click here

War in the Blood: European oncology CAR-T market access

The battle is taking shape in the burgeoning European oncology CAR-T market access space. In this feature, Research Partnership reviews the market access opportunities and challenges encountered by CAR-Ts commercialised in the EU-4 and England

Click here

CancerX looks to digital to solve cancer care access challenges

As part of the reignited Cancer Moonshot, CancerX aims to leverage digital technologies to tackle some of the biggest challenges in cancer. To find out more, pharmaphorum editor-in-chief Jonah Comstock caught up with the ringleaders behind the ambitious effort

Click here

Phesi’s Dr Gen Li on unlocking the power of data in oncology

Digital analysis, empowered by artificial intelligence, is going to transform the planning and execution of projects, says Phesi’s Dr Gen Li, but more data does not automatically equal more knowledge

Click here

Taking on the challenge of cancer drug resistance

While targeted therapies have improved cancer patient outcomes, their efficacy decreases over time as patients develop resistance to the treatments. Steven Powell, president of Ribonexus, explores promising avenues of attack to combat cancer drug resistance

Click here

The pharmaphorum podcast

Download exclusive interviews and discussions with senior pharma and biotech executives

Click here

An oncology workforce fit for the future

The future oncology workforce of the NHS needs to be flexible, comprehensive, and inclusive to continue providing high-quality, patient-centred care. Here, MSD speaks to industry experts to garner their thoughts on the workforce of the future

Click here

Around the world in pharma events

Keep up to date with important industry events taking place across the pharmaceutical industry with this interactive guide to upcoming conferences around the world

Click here

Video
Share

Your name

Your e-mail

Name receiver

E-mail address receiver

Your message

Send

Share

E-mail

Facebook

Twitter

LinkedIn

Contact

Send